IRCT20210519051345N25招募中未知
Bioequivalence study of Ursodeoxycholic acid 300mg capsule manufactured by Hakim Co. compared with innovator product
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- Male
入选标准
- •General Health (in terms of Liver, Heart and Kidney)
排除标准
- •History of cardiovascular disease, liver and kidney disease
- •Alcohol and drug addiction
- •History of drug allergy
研究者
相似试验
招募中
不适用
Investigating the in vivo bioequivalence of Ursodeoxycholic acid 300 mg capsuleIn the present study, the products will be administered to healthy volunteers..IRCT20210519051345N16Tabriz University of Medical Sciences24
招募中
Unknown
Investigating the in vivo bioequivalence of Ursodeoxycholic acid 300 mg tabletIn the present study, the products will be administered to healthy volunteers..IRCT20210519051345N30Tabriz University of Medical Sciences24
招募中
Unknown
Investigating the in vivo bioequivalence of Ursodeoxycholic acid 300 mg capsuleIn the present study, the products will be administered to healthy volunteers..IRCT20210519051345N47Tabriz University of Medical Sciences24
尚未招募
不适用
Investigating the in vivo bioequivalence of Ursodeoxycholic acid 300 mg capsuleIn the present study, the products will be administered to healthy volunteers..IRCT20210519051345N19Tabriz University of Medical Sciences24
招募中
Unknown
Investigating the in vivo bioequivalence of Ursodeoxycholic acid 300 mg capsuleIn the present study, the products will be administered to healthy volunteers..IRCT20210519051345N64Tabriz University of Medical Sciences24